Analytik Jena sales and income increase considerably

Expansion of international marketing network on schedule and introduction of new products successful

28-Aug-2001

Analytik Jena AG, supplier of analytical and bioanalytical measuring systems as well as laboratory systems, has already surpassed its sales and net income figures for the entire previous fiscal year. For the first nine months of fiscal year 2001, sales revenue rose 46.8% to EUR 23.436 million (end of 3rd quarter 2000: EUR 15.966 million). The company achieved its goals for the third quarter, taking the usual slowdown during the season into consideration during planning, thus reaffirming the company's annual sales prognosis. Sales rose 16.2% to EUR 8.187 million in the company's high-margin analytical solutions business unit (end of 3rd quarter 2000: EUR 7.044 million). The lab solutions business unit, including AJZ Engineering GmbH which has been fully consolidated into the unit since December 2000, reached sales figures of EUR 11.140 million. The high goals set for the unit were indeed met with a 105.8% increase over the same period last year. The bioanalytical solutions business unit saw an increase of 274.3% over the same period last year (end of 3rd quarter 2000: EUR 0.397 million) with sales in this, the company's newest business unit, soaring to EUR 1.486 million.

Gross profit on sales rose 43.8% to EUR 8.061 million over the first nine months last year. The total gross profit margin of 34.4% (end of 3rd quarter 2000: 35.1%) surpassed this year's goal of approx. 32.7%. This was the result of the high percentage of high-margin engineering services provided by the lab solutions business unit. In the nine months of the current fiscal year, earnings before income and taxes (EBIT) rose 14.2% to EUR 1.273 million (end of 3rd quarter 2000: EUR 1.115 million). As of 30 June 2001, earnings before taxes (EBT) rose around 75.8% over last year to EUR 1.704 million. In total, Analytik Jena AG achieved net income figures (for the quarter) of EUR 0.880 million (end of 3rd quarter 2000: EUR 0.528 million), increasing company income for this period more than 66.7% over the same period last year.

Solid financial situation ensures further growth

According to plan, inventory was expanded by 30 June 2001 in preparation for expected project and system sales during the fourth quarter, traditionally high in sales for all business units. Company liquidity dropped 32% in the last quarter following the addition of new investments, the enlargement of the company's international marketing network and the expansion of its research and development activities. As of 30 June 2001, Analytik Jena AG held EUR 10.873 million in liquid assets, corresponding to approx. 51% of the net issuing proceeds at its IPO. Liabilities rose 24.9% in comparison with the end of the last fiscal period (to 31 March 2001), increasing to EUR 17.051 million. The equity ratio of 61.7% at the end of the third quarter provides a basis for the company's solid financial situation.

Analytik Jena AG reaffirms its sales and EBIT prognoses

With a new record in order backlog of EUR 40.311 million as of 30 June 2001, approximately EUR 14 million is to be converted into additional sales during the current fiscal year ending 30 September 2001. Analytik Jena AG has thus already laid the foundations for the company's future success. Analytik Jena AG will now be able to profit from the four new products introduced during the current fiscal year by the analytical and bioanalytical solutions business areas, enabling the company to secure an even stronger market position. The progressing expansion of the company's international marketing network will also add considerable support to this positive development. Analytik Jena AG management expects higher sales levels in the fourth quarter of fiscal year 2001 than in any other quarter in company history.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!